ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 268 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q1 2018. The put-call ratio across all filers is 1.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $391,000 | -37.2% | 48,116 | -10.3% | 0.03% | +41.7% |
| Q2 2019 | $623,000 | -39.9% | 53,614 | -50.7% | 0.02% | -60.0% |
| Q1 2019 | $1,037,000 | +22.6% | 108,800 | +83.2% | 0.06% | +100.0% |
| Q3 2018 | $846,000 | +412.7% | 59,400 | +343.3% | 0.03% | +900.0% |
| Q1 2018 | $165,000 | -90.3% | 13,400 | -88.6% | 0.00% | -88.0% |
| Q4 2017 | $1,706,000 | -17.2% | 117,300 | -19.0% | 0.02% | +4.2% |
| Q3 2017 | $2,060,000 | +262.7% | 144,800 | +236.7% | 0.02% | -11.1% |
| Q1 2016 | $568,000 | -46.6% | 43,000 | -37.9% | 0.03% | -57.8% |
| Q4 2015 | $1,064,000 | +202.3% | 69,200 | +143.7% | 0.06% | +146.2% |
| Q3 2015 | $352,000 | +57.1% | 28,400 | +61.4% | 0.03% | -25.7% |
| Q4 2014 | $224,000 | -62.9% | 17,600 | -47.5% | 0.04% | +20.7% |
| Q1 2014 | $604,000 | +70.6% | 33,500 | +46.3% | 0.03% | -14.7% |
| Q4 2013 | $354,000 | – | 22,900 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,375,000 | $20,006,000 | 10.92% |
| Adirondack Research & Management Inc. | 574,033 | $8,352,000 | 3.28% |
| GLENHILL ADVISORS LLC | 2,461,034 | $35,808,000 | 2.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,949,600 | $28,367,000 | 2.42% |
| DALTON GREINER HARTMAN MAHER & CO | 2,990,902 | $43,518,000 | 2.28% |
| S&T BANK/PA | 703,223 | $10,231,000 | 1.73% |
| Tibra Equities Europe Ltd | 263,344 | $3,832,000 | 1.64% |
| Millrace Asset Group, Inc. | 116,675 | $1,697,000 | 1.63% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 1,271,450 | $18,502,000 | 1.31% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,423,223 | $137,108,000 | 1.15% |